Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by GoldCoastCRon Dec 16, 2017 8:01am
79 Views
Post# 27170513

ABM-See what they do and realize what that NR was about!

ABM-See what they do and realize what that NR was about!




 
 

Clinical Trial Services

Specializing in early phase studies across neurodegenerative and psychiatric indications

 
 

 

 

Advanced Brain Monitoring offers a full suite of leading edge EEG based sleep and daytime assessment technologies for pharmaceutical, medical device and academic clinical trials.  With expertise across a broad range of neurological disorders, our  neuroscience research team delivers streamlined EEG acquisition, secure management of data integrity, customized data analysis and worldwide clinical support.  In the below introductory overview presentation, CEO & Co-Founder Chris Berka highlights how configurable technologies combined with innovative evidence-based biomarker analyses can serve you as cost effective, noninvasive recruitment or outcome measure.

 

Neurodegenerative:

Alzheimer’s Disease
Huntington’s Disease
Parkinison’s Disease
Mild Cognitive Impairment
Frontal Temporal Dementia
Lewy Body Dementia

 

Psychiatric:

Depression
Mood
Schizophrenia
Biopolar
Insomnia

 
 

Bullboard Posts